A study shows that a cheap, decades-old chemotherapy drug extended life by more than a year when added to standard hormone therapy for men with prostate cancer that has spread.
It’s one of the biggest improvements in survival ever seen in an advanced cancer in adults.
Men who received the drug docetaxel (doe-suh-TAX-uhl) lived nearly 58 months versus 44 months for those not given the drug in the study, which was sponsored by the federal government.
- Varun Gandhi Under Attack Over Defence Deals: Here’s How
- This Diwali, Let Blind Students Brighten Up your Homes With Candles & Diyas
- CBI Files Supplementary Chargesheet In Sheena Bora Murder Case
- Soha Ali Khan And Vir Das Starrer 31st October Audience Reaction
- Sahara Chief Subrata Roy’s Parole Extended Till November 28
- Simple Tips To Secure Your Debit Card From Fraudsters
- New Zealand & India Team Being Welcomed In Chandigarh
- Mumbai Call Centre Scam: All You Need To Know
- Jammu Kashmir Chief Minister Mehbooba Mufti Appeals To Police: Here’s What She Said
- Shocker From Ahmedabad: Find Out What Happened
- Bigg Boss 10 Day 3 Review: Celebs Fail To Do Well in First Task
- Airtel Offers 10GB Data At Rs 259 For New 4G Smartphone Users
- Aamir Khan Starrer Dangal’s Trailer Launched: First Impressions
- TMC Supporters Attack BJP Leader Babul Supriyo
- Sri Lankan Navy Apprehends 20 Indian Fishermen
The results were discussed Sunday at a meeting of more than 30,000 cancer specialists in Chicago.
Doctors say it shows the importance of testing older medicines now available in generic form. This one costs about $1,500 per treatment, far less than many newer drugs.